Oxidised LDL and Anti-Oxidised LDL Antibodies Are Reduced by Lipoprotein Apheresis in a Randomised Controlled Trial on Patients with Refractory Angina and Elevated Lipoprotein(a)

• Main Authors: Tina Z. Khan (Author), Adam Hartley (Author), Dorian Haskard (Author), Mikhail Caga-Anan (Author), Dudley J. Pennell (Author), Peter Collins (Author), Mahmoud Barbir (Author), Ramzi Khamis (Author)
• Format: Book
• Published: MDPI AG, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<b>Aims:</b> An abundance of epidemiological evidence demonstrates that elevated lipoprotein(a) (Lp(a)) represents a significant contributing risk factor towards the development of cardiovascular disease. In particular, raised Lp(a) may play a mechanistic role in patients with refractory...